Section Arrow
Quote
INM.NASDAQ
- InMed Pharmaceuticals Inc
Quotes are at least 15-min delayed:2026/04/03 08:48 EDT
Regular Hours
Last
 0.678
+0.0077 (+1.15%)
Day High 
0.6805 
Prev. Close
0.6703 
1-M High
0.9529 
Volume 
23.34K 
Bid
0.6103
Ask
0.6806
Day Low
0.6351 
Open
0.67 
1-M Low
0.575 
Market Cap 
1.96M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.71 
20-SMA 0.78 
50-SMA 0.89 
52-W High 7.98 
52-W Low 0.575 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.88/-21.39
Enterprise Value
2.26M
Balance Sheet
Book Value Per Share
3.28
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
4.94M
Operating Revenue Per Share
1.42
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health19.14-0.7-3.53%38.88PE
BCRXBioCryst Pharmaceuticals9.02-0.36-3.84%7.79PE
CGCCanopy Growth Corp1+0.0256+2.63%-- 
VTRSViatris13.44-0.19-1.39%-- 
ESPREsperion Therapeutics2.61------ 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.